Filing Flows › Prelude Therapeutics (PRLD) › How it makes money
How Prelude Therapeutics (PRLD) makes money
Prelude Therapeutics (PRLD) made $5.7M of revenue in the second quarter 2026 (Q2 2026).
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $5.7M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $5.7M | — |
| Q1 2026 | $4.6M | — |
| Q4 2025 | $5.6M | +41% |
| Q3 2025 | $6.5M | +117% |
| Q4 2024 | $4.0M | — |
From Prelude Therapeutics' 10-Q filed Aug 11, 2026 (on EDGAR).
Questions
How does Prelude Therapeutics make money?
Prelude Therapeutics (PRLD) made $5.7M of revenue in the second quarter 2026 (Q2 2026).
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.